202.1(j)(1)(iii) - Providing a program to FDA for assuring that adverse information about the drug will be publicized

Prescription Drug Advertisements

OMB: 0910-0686

IC ID: 196329

Documents and Forms
Document Name
Document Type
no available documents/forms check other ICs listed under this ICR
Information Collection (IC) Details

View Information Collection (IC)

202.1(j)(1)(iii) - Providing a program to FDA for assuring that adverse information about the drug will be publicized
 
No Removed
 
Voluntary
 
21 CFR 202

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability

Health Consumer Health and Safety

 

1 0
   
Private Sector Businesses or other for-profits
 
   0 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 0 0 0 -1 0 1
Annual IC Time Burden (Hours) 0 0 0 -12 0 12
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
No associated records found
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2024 OMB.report | Privacy Policy